Overview

Donepezil Trial for Motor Recovery in Acute Stroke

Status:
Terminated
Trial end date:
2014-05-01
Target enrollment:
Participant gender:
Summary
AIMS: To establish: 1) whether motor deficits in acute stroke improve more in patients taking donepezil, relative to placebo, for 12 weeks; 2) whether brain functional MRI changes as a result of donepezil after 12 weeks.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Imperial College London
Collaborator:
International Stem Cell Forum
Treatments:
Donepezil